Can i take phosphatidylserine while taking plaquenil

Discussion in 'Online Canadian Pharmacy' started by MMikan, 19-Mar-2020.

  1. nicefoto Guest

    Can i take phosphatidylserine while taking plaquenil


    Friends and family help but they really just dont get it! Anyways- been diagnosed and have been taking plaquenil since around October- it was helping but my wrists and fingers were still in so much pain that I couldn't even get dressed in the mornings! So I was taking dose packs to help w the pain and my rheumatology finally put me on prednisone- TERRIBLE. I couldnt sleep at night, had awful night sweats, weight gain...it.

    Dizziness on plaquenil Hydroxychloroquine diagnostic studies routinely Amoebic liver abscess treatment chloroquine

    Reasons to take Phosphatidylserine in the evening 1. Phosphatidylserine may help exercise recovery and endurance. One of the lesser known benefits of PS is its ability to improve exercise recovery and endurance. Take this study for example, which suggests that 800mg/day of PS can decrease muscle soreness from physical stress. SIDE EFFECTS. The following adverse reactions have been identified during post-approval use of PLAQUENIL or other 4-aminoqunoline compounds. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. When phenothiazine medications, certain beta blockers, or certain parasite medicines are taken together with Plaquenil, interactions can occur that may affect the drug levels in your blood. This could increase your risk for side effects or decrease the effectiveness of the medicines.

    So my doctor wanted to put me on methotrexate and I read sooo many terrible things about it that I begged her to let me try something else first before going to the extreme w the methotrexate. Being a 23 yr old female who is getting married in July- weight gain feels like the worst thing that could happen to you.

    Can i take phosphatidylserine while taking plaquenil

    Strange reaction to phosphatidylserine and lithium orotate., Side Effects of Plaquenil Hydroxychloroquine, Warnings, Uses

  2. How longbto take plaquenil after alcohol
  3. Alcohol interaction is reported only by a few people who take Plaquenil. We study 48,911 people who have side effects while taking Plaquenil from Food and Drug Administration FDA. Among them, 3 have Alcohol interaction. Find out below who they are, when they have Alcohol interaction and more.

    • Will you have Alcohol interaction with Plaquenil - eHealthMe.
    • Plaquenil Interactions - eMedTV Health Information..
    • Plaquenil Hydroxychloroquine - Side Effects, Dosage..

    Sep 26, 2009 However, patients who supplement with phosphatidyl serine PS sometimes need to are able to reduce their antidepressant dosages. I'd recommend a talk with your doc about the PS and any other supplements or herbs you may be taking. She needs to be aware of everything you're taking to make sure the combination and dosages are safe and effective. So she is having me start sulfasalazine---- do any of you take this and even better do any of you take this along with plaquenil and/or prednisone because until I can wean myself off the awful prednisone I will be taking all three medicines. Hydroxychloroquine oral tablet is available as a brand-name drug and a generic drug. Brand name Plaquenil. Hydroxychloroquine comes only as a tablet you take by mouth. Hydroxychloroquine is used to treat malaria, lupus erythematosus, and rheumatoid arthritis.

     
  4. KsanDra User

    10 mg (conventional) PO q8hr or 30-60 mg (extended release) PO once daily initially; may be increased every 7-14 days PRN Maintenance: 10-20 mg (conventional) PO q8hr up to 20-30 mg PO q6-8hr; not to exceed 180 mg/day (conventional) or 120 mg/day (extended release) 30-60 mg (extended release) PO once daily; may be increased every 7-14 days PRN; not to exceed 90 mg/day (Adalat CC) or 120 mg/day (Procardia XL) 30 mg (extended-release) PO q12hr; may be increased to 120-240 mg/day (monitor) 30-120 mg (extended release) PO once daily 0.2% topical gel/ointment (extemporaneously compounded) q12hr for 3-6 weeks 20 mg sublingual Peritoneal dialysis (PD) or hemodialysis (HD): Supplemental dose not necessary Cirrhosis: Consider dose adjustment Take on empty stomach Avoid conventional (ie, immediate-release) product; potential for hypotension and risk of precipitating myocardial ischemia 10 mg (conventional) PO q8hr or 30-60 mg (extended release) PO once daily initially; may be increased every 7-14 days PRN Maintenance: 10-20 mg (conventional) PO q8hr up to 20-30 mg PO q6-8hr; not to exceed 180 mg/day (conventional) or 120 mg/day (extended release) 30-60 mg (extended release) PO once daily; may be increased every 7-14 days PRN; not to exceed 90 mg/day (Adalat CC) or 120 mg/day (Procardia XL) Adverse effects differ between short-acting (conventional) and extended-release formulations, with the conventional preparations having more serious adverse drug reactions in some cases Peripheral edema (10-30%) Dizziness (23-27%) Flushing (23-27%) Headache (10-23%) Heartburn (11%) Nausea (11%) Muscle cramps (8%) Mood change (7%) Nervousness (7%) Cough (6%) Dyspnea (6%) Palpitations (6%) Wheezing (6%) Hypotension, transient (5%) Urticaria (2%) Pruritus (2%) Constipation ( Hypersensitivity to nifedipine or other calcium-channel blockers Cardiogenic shock Concomitant administration with strong CYP3A4 inducers (eg, rifampin, rifabutin, phenobarbital, phenytoin, carbamazepine, St John's wort) significantly reduces nifedipine efficacy Immediate release preparation (sublingually or orally) for urgent or emergent hypertension Use with caution in (≤4 weeks) myocardial infarction (MI), congestive heart failure (CHF), advanced aortic stenosis, peripheral edema, symptomatic hypotension, unstable angina, concurrent use of beta blockers, hepatic or renal impairment, persistent progressive dermatologic reactions, exacerbation of angina (during initiation of treatment, after a dose increase, or after withdrawal of beta blocker) Short-acting nifedipine may be less safe than other calcium-channel blockers in management of angina, hypertension, or acute MI Use cautiously in combination with quinidine Conventional (short-acting) form not indicated for hypertension Use extended-release form with caution in severe GI stenosis; rare reports of GI obstructive symptoms in patients with known strictures or without history of GI obstruction in association with ingestion of long-acting nifedipine; bezoars can occur in very rare cases and may necessitate surgical intervention Extended-release form contains lactose; thus, patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine Cirrhosis: Clearance reduced and systemic exposure increased CYP3A inhibitors (eg, ketoconazole, fluconazole, itraconazole clarithromycin, erythromycin, grapefruit, nefazodone, saquinavir, indinavir, nelfinavir, ritonavir) may inhibit nifedipine metabolism and result in increased exposure when coadministered Strong CYP3A inducers (eg, rifampin, rifabutin, phenobarbital, phenytoin, carbamazepine, and St John’s wort) may enhance nifedipine metabolism and result in decreased exposure when coadministered Avoid use in heart failure due to lack of benefit, and/or worse outcomes with calcium channel blockers in general Use with caution in patients with hypertrophic cardiomyopathy and outflow tract obstruction; reduction in afterload may worsen symptoms associated with this condition Avoid use of immediate release formulation in the elderly; may cause hypotension and risk precipitating myocardial ischemia Pregnancy category: C Lactation: Drug is distributed into breast milk; manufacturer suggests discontinuing drug or refraining from nursing (however, American Academy of Pediatrics states that drug is safe for nursing) A: Generally acceptable. Contact the applicable plan provider for the most current information. Hydroxychloroquine as a glucose lowering drug Mixed connective tissue disease - Diagnosis and treatment. Guidelines for the Administration of Drugs Through.
     
  5. JapanRei New Member

    Selected from data included with permission and copyrighted by First Databank, Inc. Common and Rare Side Effects for Plaquenil Oral Itching From Plaquenil DailyStrength Immune & Autoimmune - Lupus Anyone Get An Itchy Rash From
     
  6. nikooo New Member

    Chloroquine Oral Uses, Side Effects, Interactions, Pictures. Find patient medical information for Chloroquine Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

    Chloroquine in Cancer Therapy A Double-Edged Sword of.
     
  7. Xandle Moderator

    Aralen - FDA prescribing information, side effects and uses Nov 21, 2019 Aralen, chloroquine phosphate, USP, is a 4-aminoquinoline compound for oral administration. It is a white, odorless, bitter tasting, crystalline substance, freely soluble in water. Aralen is an antimalarial and amebicidal drug.

    Chloroquine Oral Uses, Side Effects, Interactions, Pictures.